郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

病毒感染A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations.

期刊：Cell reports发表年份：2021作者：Federico Bertoglio; Viola Fühner; Maximilian Ruschig; Philip Alexander Heine; Leila Abassi; Thomas Klünemann; Ulfert Rand; Doris Meier; Nora Langreder; Stephan Steinke; Rico Ballmann; Kai-Thomas Schneider; Kristian Daniel Ralph Roth; Philipp Kuhn; Pe
阅读更多 →

病毒感染Comparative Efficacy of Parenteral and Mucosal Recombinant Probiotic Vaccines Against SARS-CoV-2 and S. pneumoniae Infections in Animal Models.

期刊：Vaccines发表年份：2024作者：Galina Leontieva; Tatiana Kramskaya; Tatiana Gupalova; Elena Bormotova; Yulia Desheva; Dmitry Korzhevsky; Olga Kirik; Irina Koroleva; Sergey Borisevitch; Alexander Suvorov
阅读更多 →

病毒感染Anticoronavirus Activity of Water-Soluble Pristine C60 Fullerenes: In Vitro and In Silico Screenings.

期刊：Advances in experimental medicine and biology发表年份：2021作者：Vasyl Hurmach; Maxim Platonov; Svitlana Prylutska; Zinaida Klestova; Vsevolod Cherepanov; Yuriy Prylutskyy; Uwe Ritter
阅读更多 →

病毒感染Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza.

期刊：Virology journal发表年份：2024作者：Ekaterina Stepanova; Irina Isakova-Sivak; Daria Mezhenskaya; Sergei Niskanen; Victoria Matyushenko; Ekaterina Bazhenova; Alexandra Rak; Pei Fong Wong; Polina Prokopenko; Tatiana Kotomina; Elena Krutikova; Sergei Legotskiy; Bogdan Neterebskii; Tatiana
阅读更多 →